Načítá se...
The role of combination inhaled corticosteroid/long-acting β-agonist therapy in COPD management
Chronic obstructive pulmonary disease (COPD) is now the fourth leading cause of death, affects an estimated 24 million Americans, and accounts for over ten million physician and emergency department (ED) visits and hospitalisations each year. The diagnosis and management of COPD falls largely to pri...
Uloženo v:
| Vydáno v: | Prim Care Respir J |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6602220/ https://ncbi.nlm.nih.gov/pubmed/20339822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4104/pcrj.2010.00020 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|